Dr. Robert Langer will deliver a talk titled “Biomaterials and Biotechnology: From the Discovery of Angiogenesis Inhibitors to the Development of Drug Delivery Systems and the Foundation of Tissue Engineering,” on Wednesday, May 26 at 2 p.m. in Lipsett Amphitheater, Bldg. 10. His is the first of four talks in this year’s NIDCR Seminar Series “From Basic Research to Therapy—The Latest Frontier.”
Langer will discuss his research on the development of nanoparticle- and microchip-based controlled drug delivery systems, some of which are being tested for treating cancer and other diseases. He will also describe approaches for creating novel biomaterials to treat diseases of the central nervous system. Finally, he will talk about tissue engineering technologies being developed by his laboratory for the regeneration of damaged cartilage, skin and spinal cord.
Langer is the David H. Koch institute professor at the Massachusetts Institute of Technology. He has received honorary doctorates from Harvard University, Mt. Sinai School of Medicine and Yale University, among others. In 2002, Forbes magazine selected him as one of the 15 innovators across the world who will reinvent our future. Langer has published more than 1,000 articles and has approximately 750 issued and pending patents. He holds several grants from NIH institutes, including NIDCR, NCI and NIBIB.
Sign language interpretation will be provided. For more information, or for reasonable accommodation, contact Mary Daum, (301) 594-7559, and/or the Federal Relay (1-800-877-8339).
The lecture will be videocast live at http://videocast.nih.gov.